Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002092 · ClinicalTrials.gov registry record · NA

A Study to Evaluate the Effect of Cimetidine on CD4 Lymphocyte Counts in HIV Infection

A NA study of HIV Infections, sponsored by Community Research Initiative of New England.

Completed
Registry status
NA
Development phase
1
Study location

NCT00002092: Completed NA study of HIV Infections, sponsored by Community Research Initiative of New England.

NCT00002092 is a NA study of HIV Infections that has completed, run by Community Research Initiative of New England. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002092, a NA study of HIV Infections, has completed, sponsored by Community Research Initiative of New England.

COMPLETED
Registry status
NA
Development phase
1
Study location

Study Summary

To determine the change in CD4 count after 4 and 8 weeks in HIV-infected patients treated with cimetidine compared to placebo. To observe time-associated trends at weeks 4, 8, 12, and 16 in the change of CD4 counts for patients taking cimetidine for the full 16 weeks. To establish a safety record for cimetidine use in HIV-positive patients.

Conditions Studied

HIV Infections

Interventions

  • DRUG Cimetidine

Study Locations (1)

Massachusetts

  • CRI of New England - Brookline

Trial Details

FieldValue
Phase NA

Sponsor

Community Research Initiative of New England

9 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00002092

The ClinicalTrials.gov registry entry for NCT00002092 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Community Research Initiative of New England, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Cimetidine is the first listed.

NCT00002092 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00002092 about?

NCT00002092 is a clinical study titled "A Study to Evaluate the Effect of Cimetidine on CD4 Lymphocyte Counts in HIV Infection". To determine the change in CD4 count after 4 and 8 weeks in HIV-infected patients treated with cimetidine compared to placebo. To observe time-associated trends at weeks 4, 8, 12, and 16 in the change of CD4 counts for patients taking cimetidine for the full 16 weeks. To establish a safety record fo...

What is the current status of trial NCT00002092?

This trial is currently completed. It is a NA study.

What conditions does trial NCT00002092 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT00002092?

The interventions under investigation include: Cimetidine (DRUG).

Who is sponsoring clinical trial NCT00002092?

This trial is sponsored by Community Research Initiative of New England, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002092 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.